BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34257544)

  • 1. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
    Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
    Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
    Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
    J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
    Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of
    Guo Y; Liu Y; Yang H; Dai N; Zhou F; Yang H; Sun W; Kong J; Yuan X; Gao S
    Pathol Oncol Res; 2021; 27():1609976. PubMed ID: 34955686
    [No Abstract]   [Full Text] [Related]  

  • 5. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
    Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
    Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
    Hu D; Zhang M; Peng Z
    J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
    Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
    Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
    Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
    Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liang X; Lu J; Wu Z; Guo Y; Shen S; Liang J; Dong Z; Guo W
    Mol Cancer Res; 2021 Sep; 19(9):1465-1475. PubMed ID: 34016746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
    Konishi T; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
    Am J Pathol; 2019 Oct; 189(10):1973-1985. PubMed ID: 31323188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
    Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.
    Liu B; Li X; Liu F; Li F; Wei S; Liu J; Lv Y
    Pathol Oncol Res; 2019 Oct; 25(4):1645-1652. PubMed ID: 30484263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.